journal article·2021-11-01Open access

Probing microstructural differences that manifest in human blood after taking aspirin using thixo-elasto-visco-plastic modeling and series of physical processes

Matthew Armstrong, Erin Milner, Dorian Bailey, Andre Pincot, Thomas Brown, Lam Nguyen, Kevin O’Donovan, Chi Nguyen, Trevor Corrigan

AIP Advances· Volume 11· Issue 11

Abstract

Although prophylactic use of low dosage acetylsalicylic acid (aspirin) to inhibit the effects of platelet aggregation is common, a few, if any, rheological studies validating the change in the physical and mechanical properties of human blood post-aspirin administration have been reported. Recent work modeling the rheological behavior of thixo-elasto-visco-plastic materials, such as human blood, indicates that they have all the hallmark features of a complex material, including shear-thinning, viscoelasticity, yield stress, and thixotropy. Using human blood rheological data collected on a Discovery Hybrid Rheometer, before and after a 14-day protocol of once daily 81 mg aspirin tablet, we compare the mechanical properties with the recently published enhanced thixotropic modified Horner–Armstrong–Wagner–Beris thixo-elasto-visco-plastic model and sequence of physical processes. We do so to highlight the subtle shift in mechanical properties in terms of the “liquid-like” and “solid-like” nature of blood. We will show both before and after parametric analysis, profile, and comparison, as well as the before and after aspirin elastic and viscous properties of the human blood.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Rheology and Fluid Dynamics Studies · Blood properties and coagulation · Polysaccharides Composition and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Life Science, United States Military Academy , West Point, New York 10996, USA

Funding

U.S. Army

References (75)

Show source-provided references
1. The first 3500 years of aspirin history from its roots—A concise summary10.1016/j.vph.2018.10.008 ↗
2. Usefulness of aspirin for primary prevention of atherosclerotic cardiovascular disease10.1016/j.amjcard.2019.08.040 ↗
3. Antithrombotics: From aspirin to DOACs in coronary artery disease and atrial fibrillation (part 3/5)10.1016/j.jacc.2019.02.080 ↗
4. Prevention of myocardial infarction and stroke by aspirin: Different mechanisms? Different dosage?10.1016/s0049-3848(98)00101-7 ↗
5. New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism10.2147/TCRM.S92222 ↗
6. Acetylsalicylic acid (Aspirin): A potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism10.26355/eurrev_202009_23005 ↗
7. Medicinal potential of willow: A chemical perspective of aspirin discovery10.1016/j.jscs.2010.04.010 ↗
8. Clinical pharmacokinetics of salicylates: A re-assessment10.1111/j.1365-2125.1980.tb01811.x ↗
9. Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers10.2147/CPAA.S47895 ↗
10. Antithrombotic properties of aspirin and resistance to aspirin: Beyond strictly antiplatelet actions10.1182/blood-2006-01-010645 ↗
11. 2020
12. Chapter 33—Post-transfusion red blood cell and platelet survival and kinetics: Basic principles and practical aspects
13. Historical lessons in translational medicine: Cyclooxygenase inhibition and P2Y12 antagonism10.1161/CIRCRESAHA.111.300271 ↗
14. Structure-rheology elucidation of human blood via SPP framework and TEVP modeling10.1007/s13367-021-0005-1 ↗
15. Modeling of the blood rheology in steady-state shear flows10.1122/1.4866296 ↗
16. The effect of cholesterol and triglycerides on the steady state shear rheology of blood10.1007/s00397-015-0889-0 ↗
17. Evaluating rheological models for human blood using steady state, transient, and oscillatory shear predictions10.1007/s00397-018-1109-5 ↗
18. Measurements of human blood viscoelasticity and thixotropy under steady and transient shear and constitutive modeling thereof10.1122/1.5108737 ↗
19. Investigation of blood rheology under steady and unidirectional large amplitude oscillatory shear10.1122/1.5017623 ↗
20. A critical review on blood flow in large arteries; relevance to blood rheology, viscosity models, and physiologic conditions
21. An overview of some mathematical models of blood rheology10.1007/978-1-4020-5690-1 ↗
22. Distinguishing thixotropy from viscoelasticity10.1122/8.0000262 ↗
24. The role of elasticity in thixotropy: Transient elastic stress during stepwise reduction in shear rate10.1063/5.0042579 ↗
25. On the formulation of rheological equations of state10.1098/rspa.1950.0035 ↗
26. 1987
27. 1994
28. Thixotropy—A review10.1016/s0377-0257(97)00004-9 ↗
29. Transient phenomena in thixotropic systems10.1016/s0377-0257(01)00176-8 ↗
30. A structural kinetics model for thixotropy10.1016/j.jnnfm.2006.06.002 ↗
31. M. Armstrong, “Investigating and modeling the thixotropic behavior, microstructure, and rheology of complex material,” Ph.D. thesis, University of Delaware (2015).
32. A new elastoviscoplastic model based on the Herschel–Bulkley viscoplastic model10.1016/j.jnnfm.2008.12.001 ↗
33. Modeling the thixotropic behavior of structured fluids10.1016/j.jnnfm.2009.08.005 ↗
34. Describing and prescribing the constitutive response of yield stress fluids using large amplitude oscillatory shear stress (LAOStress)10.1122/1.4754023 ↗
35. A comprehensive constitutive law for waxy crude oil: A thixotropic yield stress fluid10.1039/c4sm00578c ↗
36. A canonical framework for modeling elasto-viscoplasticity in complex fluids10.1016/j.jnnfm.2018.10.004 ↗
37. A multimode structural kinetics constitutive equation for the transient rheology of thixotropic elasto-viscoplastic fluids10.1122/1.4996752 ↗
38. Modeling the rheology of thixotropic elasto-visco-plastic materials10.1122/1.5049136 ↗
39. Modeling of human blood rheology in transient shear flows10.1122/1.4904423 ↗
40. 1980
42. New measures for characterizing nonlinear viscoelasticity in large amplitude oscillatory shear10.1122/1.2970095 ↗
43. A geometrical interpretation of large amplitude oscillatory shear response10.1122/1.1895801 ↗
44. A methodology for adding thixotropy to Oldroyd-8 family of viscoelastic models for characterization of human blood10.1063/5.0022501 ↗
45. In search of physical meaning: Defining transient parameters for nonlinear viscoelasticity10.1007/s00397-017-1008-1 ↗
46. Yielding and recovery of conductive pastes for screen printing10.1007/s00397-019-01148-w ↗
47. A sequence of physical processes determined and quantified in large amplitude oscillatory shear (LAOS): Application to theoretical nonlinear models10.1122/1.3662962 ↗
48. Integration of thixotropy into Giesekus model for characterization of human blood10.1063/5.0045578 ↗
49. Blood rheology in arterial disease10.1042/cs0710137 ↗
50. An adaptive parallel tempering method for the dynamic data-driven parameter estimation of nonlinear models10.1002/aic.15577 ↗
51. Etude expérimentale IN VITRO du comportement rhéologique du sang en régime transitoire a faible vitesse de cisaillement10.1007/bf01522034 ↗
52. Etude rhéologique en régime transitoire de quelques échantillons de sangs humains artificiellement modifies10.1007/bf01533351 ↗
53. Rheological hysteresis of blood at low shear rate10.3233/bir-1980-171-221 ↗
54. Shear viscosity and nonlinear behavior of whole blood under large amplitude oscillatory shear10.3233/bir-130643 ↗
55. Effects of ex vivo aging and storage temperature on blood viscosity10.3233/ch-170330 ↗
56. Visualizing and exploring nonlinear behavior, timescales, and mechanical signatures of human blood10.3233/bir-201007 ↗
57. Dynamic shear rheology of a thixotropic suspension: Comparison of an improved structure-based model with large amplitude oscillatory shear experiments10.1122/1.4943986 ↗
58. Interpretation of the correlation coefficient: A basic review10.1177/875647939000600106 ↗
59. 2011
60. The suspension stability of the blood10.1152/physrev.1929.9.2.241 ↗
61. Effect of cholesterol and triglycerides levels on the rheological behavior of human blood10.1007/s13367-015-0001-4 ↗
62. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA10.1161/strokeaha.107.496281 ↗
63. Mapping thixo-elasto-visco-plastic behavior10.1007/s00397-017-1001-8 ↗
64. Understanding thixotropic and antithixotropic behavior of viscoelastic micellar solutions and liquid crystalline dispersions. I. The model10.1016/s0377-0257(98)00081-0 ↗
65. 1999 · 1
66. A simple thixotropic–viscoelastic constitutive model produces unique signatures in large-amplitude oscillatory shear (LAOS)10.1016/j.jnnfm.2014.03.006 ↗
67. A simple constitutive equation for polymer fluids based on the concept of deformation-dependent tensorial mobility10.1016/0377-0257(82)85016-7 ↗
68. Contemporary modeling and analysis of steady state and transient human blood rheology10.1007/s00397-017-1062-8 ↗
69. Effects of aspiring on rheological properties of erythrocytes in vitro10.59566/IJBS.2012.8188 ↗
70. Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease10.1016/j.lab.2005.12.005 ↗
71. Erythrocyte promotion of platelet activity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: The effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet activity10.1161/01.cir.97.4.350 ↗
72. 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives
73. Drug-induced thrombophilic or prothrombotic states: An underestimated clinical problem that involves both legal and illegal compounds10.1177/1076029616652724 ↗
74. The effect of aspirin on rheological properties of erthyrocytes in essential hypertension
75. M. Armstrong and T. Corrigan (2021). “USMA Aspirin Study–pre and post human blood rheology,” Mendeley, Dataset. 10.17632/dttytm73pn.1